| 2025年年报 | 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| 面部埋植线(元) | - | 3,321,101.78 | 6,804,226.47 | 3,479,604.87 |
| 凝胶类注射产品(元) | 889,648,520.93 | 493,266,121.88 | 1,215,722,744.70 | 648,973,603.34 |
| 溶液类注射产品(元) | 1,264,696,679.60 | 744,000,729.46 | 1,743,949,380.33 | 976,281,612.43 |
| 冻干粉类注射产品(元) | 208,077,615.07 | 19,465,524.01 | - | - |
| 其他(元) | 90,194,345.84 | 39,129,009.13 | 59,192,097.97 | 28,175,141.77 |
| 营业成本(元) | ||||
| 面部埋植线(元) | - | 658,187.28 | 1,053,278.24 | 555,422.43 |
| 凝胶类注射产品(元) | 23,808,387.12 | 11,121,498.51 | 24,575,944.29 | 13,131,244.80 |
| 溶液类注射产品(元) | 87,181,213.62 | 50,958,880.19 | 108,832,409.07 | 58,766,064.47 |
| 冻干粉类注射产品(元) | 33,830,644.59 | 4,868,016.60 | - | - |
| 其他(元) | 34,268,338.01 | 17,674,746.33 | 27,754,859.66 | 11,815,412.73 |
| 毛利(元) | ||||
| 面部埋植线(元) | - | 2,662,914.50 | 5,750,948.23 | 2,924,182.44 |
| 凝胶类注射产品(元) | 865,840,133.81 | 482,144,623.37 | 1,191,146,800.41 | 635,842,358.54 |
| 溶液类注射产品(元) | 1,177,515,465.98 | 693,041,849.27 | 1,635,116,971.26 | 917,515,547.96 |
| 冻干粉类注射产品(元) | 174,246,970.48 | 14,597,507.41 | - | - |
| 其他(元) | 55,926,007.83 | 21,454,262.80 | 31,437,238.31 | 16,359,729.04 |
| 毛利率(%) | ||||
| 面部埋植线(%) | - | 80.18 | 84.52 | 84.04 |
| 凝胶类注射产品(%) | 97.32 | 97.75 | 97.98 | 97.98 |
| 溶液类注射产品(%) | 93.11 | 93.15 | 93.76 | 93.98 |
| 冻干粉类注射产品(%) | 83.74 | 74.99 | - | - |
| 其他(%) | 62.01 | 54.83 | 53.11 | 58.06 |
| 收入构成(%) | ||||
| 面部埋植线(%) | - | 0.26 | 0.22 | 0.21 |
| 凝胶类注射产品(%) | 36.27 | 37.97 | 40.18 | 39.17 |
| 溶液类注射产品(%) | 51.57 | 57.27 | 57.64 | 58.92 |
| 冻干粉类注射产品(%) | 8.48 | 1.50 | - | - |
| 其他(%) | 3.68 | 3.01 | 1.96 | 1.70 |
| 毛利构成(%) | ||||
| 面部埋植线(%) | - | 0.22 | 0.20 | 0.19 |
| 凝胶类注射产品(%) | 38.08 | 39.72 | 41.60 | 40.43 |
| 溶液类注射产品(%) | 51.79 | 57.09 | 57.10 | 58.34 |
| 冻干粉类注射产品(%) | 7.66 | 1.20 | - | - |
| 其他(%) | 2.46 | 1.77 | 1.10 | 1.04 |